Gossamer Bio annual return on equity
2019
2020
2021
2022
2023
2024
Gossamer Bio Return on Equity (ROE) Growth & History (GOSS)
Gossamer Bio's return on equity was −122.54% for fiscal 2024.
View full Gossamer Bio company overviewGossamer Bio annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −122.54% | +357.96 pp |
| 2023 | 2023-12-31 | −480.50% | −136.96 pp |
| 2022 | 2022-12-31 | −343.53% | −237.69 pp |
| 2021 | 2021-12-31 | −105.85% | −33.55 pp |
| 2020 | 2020-12-31 | −72.30% | +82.86 pp |
| 2019 | 2019-12-31 | −155.16% | — |
Gossamer Bio quarterly return on equity
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −315.27% | −221.57 pp |
| Q4 2024 | 2024-12-31 | −78.99% | −21.46 pp |
| Q3 2024 | 2024-09-30 | −45.41% | +145.94 pp |
| Q2 2024 | 2024-06-30 | 90.96% | — |
| Q1 2024 | 2024-03-31 | −93.70% | — |
| Q4 2023 | 2023-12-31 | −57.53% | +105.46 pp |
| Q3 2023 | 2023-09-30 | −191.35% | +106.29 pp |
| Q4 2022 | 2022-12-31 | −162.99% | −124.34 pp |
| Q3 2022 | 2022-09-30 | −297.63% | −266.78 pp |
| Q2 2022 | 2022-06-30 | −824.44% | −800.16 pp |
| Q1 2022 | 2022-03-31 | −76.22% | −56.77 pp |
| Q4 2021 | 2021-12-31 | −38.65% | −20.00 pp |
| Q3 2021 | 2021-09-30 | −30.86% | −16.27 pp |
| Q2 2021 | 2021-06-30 | −24.28% | −5.88 pp |
| Q1 2021 | 2021-03-31 | −19.45% | −3.04 pp |
| Q4 2020 | 2020-12-31 | −18.65% | −4.09 pp |
| Q3 2020 | 2020-09-30 | −14.59% | −3.05 pp |
| Q2 2020 | 2020-06-30 | −18.40% | −8.75 pp |
| Q1 2020 | 2020-03-31 | −16.41% | +1.70 pp |
| Q4 2019 | 2019-12-31 | −14.56% | — |
| Q3 2019 | 2019-09-30 | −11.54% | — |
| Q2 2019 | 2019-06-30 | −9.66% | — |
| Q1 2019 | 2019-03-31 | −18.11% | — |
Gossamer Bio return on equity trends
Over the last five fiscal years, Gossamer Bio's return on equity increased from −155.16% to −122.54%, a change of +32.62 percentage points. The latest reported quarter, Q1 2025, shows −315.27%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gossamer Bio source filings ↗